Six studies, including the Grasso, Taylor, Yu, Holzbeierlein, LaTulippe and Ramaswamy cohorts in the Oncomine database, showed that UBE2S was expressed at higher levels in metastases than at the primary site in PCa (Fig. 5I-N). The gene discussed is UBE2S; the disease is posterior cortical atrophy.